Sirolimus-eluting stent

DEVICE10 trials

Sponsors

Deutsches Herzzentrum Muenchen, R&D Cardiologie, Antwerp Cardiovascular Institute Middelheim, University of Bern, Seung-Jung Park

Conditions

Arteriosclerosis of Arterial Coronary Artery Bypass GraftCoronary Artery DiseaseCoronary DiseaseCoronary Heart DiseaseCoronary StenosisDrug-coated BalloonIn Stent RestenosisSaphenous Vein Graft Disease

Phase 2

RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.

CompletedNCT00263263

Antwerp Cardiovascular Institute MiddelheimCoronary Artery Disease, Saphenous Vein Graft Disease, Stable Angina +1

Start: 2003-09-30End: 2005-12-31Target: 75Updated: 2007-03-14

Phase 3

Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions

CompletedNCT00258596

R&D CardiologieCoronary Artery Disease, Coronary Disease, Coronary Stenosis

Start: 2003-01-31End: 2006-09-30Target: 200Updated: 2007-03-06

Phase 4

Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)

CompletedNCT00133237

Deutsches Herzzentrum MuenchenCoronary Disease

Start: 2005-07-31End: 2008-06-30Updated: 2010-03-15

Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization

CompletedNCT00297661

University of BernCoronary Heart Disease

Start: 2003-04-30Target: 1012Updated: 2006-10-20

Focal In-stent Restenosis After Drug-Eluting Stent

CompletedNCT00485004

Seung-Jung ParkIn Stent Restenosis

Start: 2007-03-31End: 2011-03-31Updated: 2012-08-08

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions

CompletedNCT00611910

Deutsches Herzzentrum MuenchenArteriosclerosis of Arterial Coronary Artery Bypass Graft

Start: 2007-11-30End: 2011-03-31Updated: 2011-05-13

Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial

CompletedNCT01035450

Takeshi MorimotoCoronary Artery Disease

Start: 2010-02-28End: 2014-05-31Updated: 2015-12-10

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

CompletedNCT01502904

Yonsei UniversityStable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension

Start: 2010-07-31End: 2015-06-30Updated: 2016-07-27

Unknown Phase

Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion

CompletedNCT01887704

Capital Medical UniversityCoronary Artery Disease

Start: 2010-01-31End: 2013-05-31Updated: 2013-06-27

Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions

Lepu Medical Technology (Beijing) Co., Ltd.Coronary Artery Disease, Drug-coated Balloon

Start: 2021-10-31End: 2023-11-30Target: 400Updated: 2021-10-29

Related Papers

7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial.

2019-04-0119 citations

Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.

2018-05-0143 citations

Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: a patient-level pooled analysis from the 4 large-scale Japanese studies.

2018-03-052 citations

Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial

European Heart Journal2016-08-3094 citations

Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity

Circulation Cardiovascular Interventions2016-01-29116 citations

Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.

2015-12-2213 citations

Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention

EuroIntervention2015-06-0110 citations

The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.

2014-05-1420 citations

Long-Term Clinical Outcomes After Everolimus- and Sirolimus-Eluting Coronary Stent Implantation

Circulation Cardiovascular Interventions2014-05-0741 citations

Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.

2013-12-1133 citations

Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).

2012-07-23100 citations

Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents.

2012-03-0149 citations

SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial.

2011-09-27107 citations

Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.

2011-08-26110 citations

Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation.

2010-03-01112 citations

Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

2009-05-01114 citations

Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.

2007-09-0454 citations